A New Tinnitus CURE? | OTO-313. Dr. Cliff Olson
Audiologist and founder of Applied Hearing Solutions in Phoenix Arizona, discusses a drug that is currently undergoing FDA clinical trials to see if it could be a CURE for Tinnitus. Check out the NeuroTinnitus Brain Retraining Program: https://www.neurotinnitus.com/go?affiliate_id=2431398
American Tinnitus Association: https://ATA.org
OTO-313 Clinical Trials: https://clinicaltrials.gov/ct2/show/NCT03918109
A cure for tinnitus is something that has eluded researchers. With millions of individuals world wide suffering from this annoying condition that causes ringing in the ears, a cure is something that the world is in desperate need of. A pharmaceutical company Otonomy is trying to change that. They are searching for a cure for tinnitus and other ear related conditions. By using Gacyclidine a non-competitive NMDA receptor antagonist, is a Phencyclidine derivative with neuroprotective properties, they hope to reverse tinnitus or at least suppress it. Gacyclidine is closely related to another drug called Phencyclidine which is more commonly known as PCP, which is a hallucinogenic drug. Currently in Phase 1/2 of FDA clinical trials, they hope to show a positive impact of Gacyclidine on tinnitus. Results of their safety and efficacy trials should be published by the end of 2020.
DISCLAIMER: This description contains affiliate links, which means that if you click on one of the product links, I’ll receive a small commission. This helps support the channel and allows us to continue to make videos like this. Thank you for the support!